Google postpones Manifest destiny again for Chrome extension platform
"As we head towards Manifest V3 migration, we are intently monitoring comments from the developer community to help inform our timelines," said Vincent."We’ve heard your feedback on common challenges posed by the migration, specifically the service worker’s inability to use DOM capabilities and the current hard limit on extension service worker lifetimes. We’re mitigating the former with the Offscreen Documents API and are actively pursuing a solution to the latter.
Vincent said Google is"committed to providing developers solutions to migration challenges with new functionality, bug fixes, and adequate time for adoption." And thus the company has decided to postpone its plan in January to begin disabling MV2 extensions in pre-release channels – various versions of Chrome used by developers. It is also reconsidering"all downstream milestones" too.
Vincent said to expect an update in March next year."Our guiding principle will be to give developers sufficient time to update and test their extensions after the launch of these new capabilities before turning off Manifest V2," he said., only about 30,000 of about 166,000 extensions in the Chrome Web Store have been converted from MV2 to to MV3:
"As of today, only 17.84 per cent of all items in [the] Chrome Web Store have migrated to Manifest V3. If the timeline is strictly followed, the vast majority of Chrome extensions may stop working." Most ofAt some point, MV2 extensions will be disabled in Chrome. We should learn more within three months or so. ®
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Millions must check Google settings now – it could save you from major dangerAN AMAZING new Google feature lets you ditch passwords for a safer alternative. Passwords are famously dangerous (even if you have a strong one), but a new Google Chrome update ushers in a password…
Lire la suite »
Japan, Australia, to bolster cyber-defensesFTX Japan payment promise evaporates; VR/AR to boom across APAC; Google wins privacy case
Lire la suite »
So-called ‘gaming Chromebooks’ are a con – here’s whyChrome OS could be the new frontier for gaming… or not
Lire la suite »
'My periods can make me black out and vomit. Why haven't I had any treatment?''When you google endometriosis you find so many horror stories. But in real life it actually is a horror story.'
Lire la suite »
Parameters associated with successful weaning of veno-arterial extracorporeal membrane oxygenation: a systematic review - Critical CarePurpose Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO) can be used to restore organ perfusion in patients with cardiogenic shock until native heart recovery occurs. It may be challenging, however, to determine when patients can be weaned successfully from ECMO—surviving without requiring further mechanical support or heart transplant. We aimed to systematically review the medical literature to determine the biomarkers, hemodynamic and echocardiographic parameters associated with successful weaning of VA-ECMO in adults with cardiogenic shock and to present an evidence-based weaning algorithm incorporating key findings. Method We systematically searched PubMed, Embase, ProQuest, Google Scholars, Web of Science and the Grey literature for pertinent original research reports. We excluded studies limited to extracorporeal cardiopulmonary resuscitation (ECPR) as the neurological prognosis may significantly alter the decision-making process surrounding the device removal in this patient population. Studies with a mixed population of VA-ECMO for cardiogenic shock or cardiac arrest were included. We excluded studies limited to patients in which ECMO was only used as a bridge to VAD or heart transplant, as such patients are, by definition, never “successfully weaned.” We used the Risk of Bias Assessment tool for Non-Randomized Studies. The study was registered on the International prospective register of systematic reviews (PROSPERO CRD42020178641). Results We screened 14,578 records and included 47 that met our pre-specified criteria. Signs of lower initial severity of shock and myocardial injury, early recovery of systemic perfusion, left and right ventricular recovery, hemodynamic and echocardiographic stability during flow reduction trial and/or pump-controlled retrograde trial off predicted successful weaning. The most widely used parameter was the left ventricular outflow tract velocity time integral, an indicator of stroke volume. Most studies had a mode
Lire la suite »
New Harry and Meghan Netflix trailer feels like a family drama with no happy endingHere we go again.
Lire la suite »